KELLY HOST: Open Payments
NPI 1861698664 · SUFFOLK, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$448 in 23 payments from 11 companies in 2025. Trend: 2023 $429 · 2024 $414 · 2025 $448
Food & beverage: $448
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 5 | $90 |
| Exeltis, USA Inc. | 3 | $67 |
| Astellas Pharma US Inc | 3 | $63 |
| MILLICENT US INC | 3 | $52 |
| Organon LLC | 3 | $48 |
| Novo Nordisk Inc | 1 | $29 |
| SHIELD THERAPEUTICS INC | 1 | $24 |
| CooperSurgical, Inc. | 1 | $23 |
| Biogen, Inc. | 1 | $22 |
| Exact Sciences Corporation | 1 | $15 |
Products named: INJECTAFER, SLYND, Veozah, NEXPLANON, FEMRING, Wegovy, ACCRUFER, Paragard T 380A.
Industry payments across VA — which companies pay providers there.
